Repare Therapeutics Q1 EPS $0.30 Beats $0.02 Estimate, Sales $52.40M Beat $38.40M Estimate
Portfolio Pulse from Benzinga Newsdesk
Repare Therapeutics (NASDAQ:RPTX) reported Q1 earnings of $0.30 per share, surpassing the $0.02 estimate, a 136.14% increase from last year's losses. Sales reached $52.40M, beating the $38.40M estimate, marking an 822.93% increase from the previous year.
May 07, 2024 | 9:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Repare Therapeutics reported a significant beat on both earnings and sales estimates for Q1, with earnings of $0.30 per share and sales of $52.40M.
The substantial beat on both earnings per share and sales estimates, with a 136.14% increase in earnings from the previous year and an 822.93% increase in sales, indicates strong company performance and operational efficiency. This is likely to positively influence investor sentiment and could lead to a short-term uptick in RPTX's stock price.
CONFIDENCE 90
IMPORTANCE 95
RELEVANCE 100